Zobrazeno 1 - 10
of 48
pro vyhledávání: '"Jean-Louis Peglion"'
Autor:
Elsa P. Bianchini, Jean Louis Peglion, Allan De Carvalho, Stéphane Pautus, Alain Rupin, Mouad Alami, Gilles Ferry, Natacha Bonneau, Jean Daniel Brion, Pierre Champy, Philippe Gloanec, Daniel A. Lawrence, Guillaume Bernadat, Frédéric Adam, Delphine Borgel, Abdallah Hamze
Publikováno v:
Scientific Reports
Plasminogen activator inhibitor-1 (PAI-1) is the main inhibitor of the tissue type and urokinase type plasminogen activators. High levels of PAI-1 are correlated with an increased risk of thrombotic events and several other pathologies. Despite sever
Publikováno v:
European Neuropsychopharmacology. 19:887-897
Though serotonergic mechanisms modulate circadian rhythms, roles of individual serotonin (5-HT) receptors remain uncertain since data are lacking for antagonists. Herein, both the 5-HT(5A) receptor antagonist, A843277 (10 mg/kg), and the 5-HT(1B) ant
Publikováno v:
Tetrahedron. 64:5703-5710
Octalactin B was synthesized from the commercially available methyl-3-butenoate and isobutyraldehyde, using enantioselective allyl- and crotyltitanations to control the stereogenic centers at C3, C4, C7, C8, and C13. Moreover, the two other key-step
Autor:
Francis Cogé, Pascale Chomarat, Guillaumin Jp, Stephane Bedut, Brunel-Jacquemin C, Jean-Louis Peglion, Piffard L, Nicole Villeneuve, Catherine Thollon, Jean A. Boutin, Jean-Paul Vilaine
Publikováno v:
British Journal of Pharmacology. 150:37-46
Background and purpose: Ivabradine, a specific and use-dependent If inhibitor, exerts anti-ischaemic activity purely by reducing heart rate. The aim of this work was to characterize its effect on the predominant HCN channel isoform expressed in human
Autor:
Roger D. Porsolt, J M Rivet, Pierre Lestage, Anne Dekeyne, Robert Jaffard, Jean Louis Peglion, Alain P. Gobert, Elisabeth Mocaer, Benjamin Di Cara, Mirjana Carli, Sylvain Roux, Alfredo Meneses, Millan Mark
Publikováno v:
Journal of Pharmacology and Experimental Therapeutics. 311:190-203
These studies examined the influence of the selective 5-hydroxytryptamine (serotonin) (5-HT)(1A) receptor partial agonist S15535 [4-(benzodioxan-5-yl)1-(indan-2-yl)piperazine] upon cholinergic transmission and cognitive function in rodents. In the ab
Autor:
Jean-Michel Rivet, Françoise Lejeune, Alain P. Gobert, Clotilde Mannoury la Cour, Jean-Louis Peglion, Millan Mark, Didier Cussac, Adrian Newman-Tancredi
Publikováno v:
Journal of Pharmacology and Experimental Therapeutics. 309:903-920
S32504 [(+)-trans-3,4,4a,5,6,10b-hexahydro-9-carbamoyl-4-propyl-2H-naphth[1,2-b]-1,4-oxazine] displayed marked affinity for cloned, human (h)D(3) receptors (pK(i), 8.1) at which, in total G-protein ([(35)S]GTPgammaS binding, guanosine-5'-O-(3-[(35)S]
Publikováno v:
Journal of Cardiovascular Pharmacology. 42:688-696
The effects of ivabradine, a novel heart rate-reducing agent that inhibits the cardiac pacemaker current If, were compared with those of the beta-adrenergic blocker propranolol, in a model of exercise-induced regional myocardial ischemia in pigs. Fiv
Publikováno v:
European Heart Journal Supplements. 5:G26-G35
Procoralan (S 16257-2) is a selective inhibitor of the pacemaker If current. It reduces in vitro the spontaneous beating rate of the sinus node by slowing the diastolic depolarization slope of the action potential. It induces in vivo a selective and
Autor:
Patrick Genissel, Anne Dekeyne, Adrian Newman-Tancredi, Bertrand Goument, Marc Bertrand, Millan Mark, Valérie Charlot, Jean-Louis Peglion, Christian Nisole, Hélène Giraud, Nicole Despaux
Publikováno v:
Journal of Medicinal Chemistry. 45:165-176
S 15535 (1) displays a distinctive profile of agonist and antagonist (weak partial agonist) activity at pre- and postsynaptic 5-HT(1A) receptors, respectively. It has proven to be active in several models predictive of anxiolytic, antidepressant, and
Publikováno v:
Tetrahedron Letters. 39:2965-2968
The synthesis of spiro[quinoline-2,4′-piperidines] by using a radical or a Heck reaction, as the key step, is described.